Auxogyn

Auxogyn was co-founded by pioneering scientists from Stanford University (Professor Renee Reijo Pera, PhD, and colleagues Dr. Barry Behr, Dr. Thomas Baer, postdoctoral researcher Dr. Connie Wong, and Dr. Kevin Loewke). They conducted landmark research that provided the first link between embryonic development outcomes, cell division events, and embryonic molecular health. Auxogyn continues to provide new clinical and scientific benchmarks that reproductive endocrinologists and their patients can use to make critical decisions during the process of infertility treatment.